Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 24Completed 23Unknown 13Active not recruiting 12Not yet recruiting 10Terminated 7Withdrawn 2Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Microsatellite-stable Colorectal Cancer 1Colonic Neoplasms 1

Interventions

Specimen Handling 11Magnetic Resonance Spectroscopy 9Cyclophosphamide 9Bevacizumab 7pembrolizumab 6Radiosurgery 6Cisplatin 6Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5venetoclax 4Vincristine 4S 1 (combination) 4Prednisone 4Leucovorin 4Etoposide 4Drug Therapy 4Doxorubicin 4Biopsy 4Azacitidine 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Rituximab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × OTHER × trifluridine tipiracil drug combination × Clear all
NCT07011550 2026-03-20

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Suspended
7 enrolled
Gastrointestinal

Microsatellite-stable Colorectal Cancer

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended
477 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡